bioTheranostics, a bioMérieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.
pr_22022010_small_thumb18.jpg bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of its new, ready-to-use culture medium, CampyFood Broth (CFB) for the detection and enumeration of Campylobacter spp. This innovative broth will provide food processing companies with simple, complete and high quality solutions to help ensure the safety of their food products.
Solution Fully Validated and Recognized as an Official MethodSM
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2009.
3_vidasslide31_thumb16.jpg VIDAS® LMX, a New VIDAS Next Day test for food and environmental testing.
Company to leverage new production site to capture growth in China and expand Point of Care and rapid diagnostics offer for both emerging and developed countries
Physicians Attribute Antimicrobial Resistance and the Spread of Multi-Drug Resistant Organisms (MDRO) to Antibiotic Overuse
Fully automated handheld diagnostic test devices designed to improve diagnosis and disease management in critical care settings within hospitals.
New test provides physicians with additional information which may eliminate invasive biopsies
bioMérieux, a world leader in the field of in vitro diagnostics, has been named the recipient of the Rising Star Award by National Distribution & Contracting, Inc. (NDC) for its outstanding service and support in the physician office market.
